Resistance-associated polymorphisms in Dutch hepatitis C genotype 1a patients with and without HIV infection



Título del documento: Resistance-associated polymorphisms in Dutch hepatitis C genotype 1a patients with and without HIV infection
Revista: Annals of hepatology
Base de datos: PERIÓDICA
Número de sistema: 000407165
ISSN: 1665-2681
Autors: 1
2
3
3
3
3
4
5
5
6
1
1
1
Institucions: 1University Medical Center Utrecht, Department of Gastroenterology and Hepatology, Utrecht. Países Bajos
2University Medical Center Utrecht, Department of Medical Microbiology, Utrecht. Países Bajos
3Academic Medical Center, Department of Medical Microbiology, Amsterdam. Países Bajos
4Academic Medical Center, Department of Internal Medicine and Infectious Diseases, Amsterdam. Países Bajos
5University Medical Center Utrecht, Department of Internal Medicine and Infectious Diseases, Utrecht. Países Bajos
6University Medical Center Utrecht, Department of Medical Microbiology, Utrecht. Países Bajos
Any:
Període: Sep-Oct
Volum: 15
Número: 5
Paginació: 696-704
País: México
Idioma: Inglés
Tipo de documento: Artículo
Enfoque: Analítico, descriptivo
Resumen en inglés Resistanc Background and aim. e-associated variants (RAVs) on the NS3 region of the hepatitis C virus (HCV) may be relevant for antiviral therapy, but data in human immunodeficiency virus (HIV) coinfected patients are scarce. We assessed frequencies of NS3 RAVs in patients infected with HCV genotype 1a with or without HIV coinfection. Material and methods. Material and methods. HCV NS3 amino Material and methods. acids 1-181 were sequenced by the Sanger method and analyzed for RAVs. RAVs and their distribution between HCV genotype 1a clade I and II viruses were compared between HIV-infected versus HIV-uninfected patients. Results. Results. 148 Results. samples were available (n = 68 HIV and n = 80 non-HIV). Relative frequency of clade I and clade II was significantly different between HIV (85% and 15%) and non-HIV groups (49% and 51%). Overall, HIV infected patients exhibited significantly lower prevalence of RAVs than HIV-uninfected patients (62% vs. 79%, p = 0.03). However, Q80K prevalence was significantly higher in HIV-infected subjects (50% vs. 24%, p = 0.001), whereas prevalence of S122D/G/N/S (2% vs. 16%, p = 0.002) and N174G/N/S (10% vs. 55%, p < 0.0001) polymorphisms were significantly lower. Q80K was found exclusively in clade I viruses. S122 (3% vs. 22%, p=0.001) and N174 (13% vs. 75%, p<0.0001) polymorphisms had significantly lower prevalence in clade I than clade II viruses. Conclusions. Conclusions. In Conclusions. the Netherlands, prevalence of clade I viruses and Q80K was significantly higher in HCV genotype 1a infected patients with HIV coinfection than in those without HIV coinfection. Prevalence of N174 and S122 polymorphisms was significantly higher in clade II than clade I viruses
Disciplines Medicina
Paraules clau: Gastroenterología,
Microbiología,
Hepatitis C,
Virus de la hepatitis C,
Resistencia a fármacos,
Antivirales,
Polimorfismo genético,
VIH
Keyword: Medicine,
Gastroenterology,
Microbiology,
Hepatitis C,
Hepatitis C virus,
Drug resistance,
Antiviral agents,
Genetic polymorphism,
HIV
Text complet: Texto completo (Ver PDF)